BMO Capital initiated coverage of Kyndryl (KD) with a Market Perform rating and $15 price target The company’s fiscal 2028 targets are “too aggressive,” the analyst tells investors in a research note. BMO’s estimates are below management’s targets. It views the “current discounted valuation as reasonable” and does not see catalysts for a move higher.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KD:
- Versant Media, Crocs, SLM new positions for Einhorn’s Greenlight
- Kyndryl awarded Texas Department of Information Resources contract
- Investors Sue Kyndryl Over ‘Misleading’ Financial Statements
- Kyndryl price target lowered to $13 from $28 at Morgan Stanley
- Kyndryl: Limited Near-Term Upside Amid Uncertain Growth Outlook and Evolving IBM Partnership